Skip to content

Gelsoft Plus™ 633010PRecalls & reported problems

Vascutek Ltd · Gelsoft Plus Gelatin Impregnated Knitted Vascular Prosthesis STRAIGHT · Class 2 · Implant

Adverse event reports
2
Deaths reported
1
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 05037881115238), received between May 29, 2024 and Nov 11, 2024 — classified as 1 death, 1 malfunction.

The most frequently reported specific device problem is “Misconnection” (1 report).

1 other recall cover devices cleared under the same FDA submission (K162803, K955230); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 1 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 1 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Misconnection1
  • Off-Label Use1

Patient problems

  • Hemorrhage/Blood Loss/Bleeding1
  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionNov 11, 2024Off-Label Use; Off-Label Use

    EVENT DATE: ON 16 OCT 2024. IMPLANT DATE: ON (B)(6) 2024. EVENT WAS REPORTED AS WEAVING DEFECTS. THE SURGICAL GRAFT WAS USED AS A CIRCULATION LINE FOR AORTIC REPLACEMENT PROCEDURE, AND AFTER CLAMP RELEASED, SURGEON FOUND BLOOD EJECT FROM THE SURFACE OF SURGICAL GRAFT (NOT THE ANASTOMOSIS SITE).

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 20650845 ↗
  • DeathMay 29, 2024Misconnection; Misconnection

    EVENT REPORTED BY EMAIL FROM CARDIOTHORACIC BUSINESS MANAGER ON 02 MAY 24 GELSOFT PLUS STRAIGHT GRAFT IMPLANTED IN (B)(6) HOSPITAL WAS LEAKING THROUGH THE GRAFT , NOT AT THE ENDS. GRAFT WAS SUCCESSFULLY IMPLANTED. EVENT INTAKE FORM WAS RECEIVED ON 08 MAY 24 10MM GRAFT WAS BEING USED FOR CANNULATION AND WAS NOT IMPLANTED HOWEVER IT HAS BEEN DISGARDED AND IS NO LONGER AVAILABE TO BE RETURNED. PATIENT PRE-CONDITION WAS ENTERED AS POSTOP VSD - VENTRICULAR SEPTAL DEFECT. POOR LEFT VENTRICULAR AND RIGHT VENTRICULAR FAILURE PREPARATION FOR ECMO ,THE PATIENT HAS SINCE PASSED AWAY, CLINICIAN STATED " THE CONDUIT ISSUE IS NOT A CAUSE OF DEATH". AS PER EVENT INTAKE FORM THIS WAS NOT RELATED TO A DEVICE FAILURE/ DEFICIENCY. THIS REPORT IS BEING SUBMITTED TO PROVIDE INITIAL - FINAL EVENT INFORMATION FOR MANUFACTURING REPORT #0612515-2024-00032 COMPLAINT (B)(4).

    Patient problems: Hemorrhage/Blood Loss/Bleeding

    MAUDE report 19414780 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K162803, K955230. One submission often covers many models, so check the product and lot details in each record.

  • Z-2542-2021 · Jul 8, 2021 · Terminated
    The Instructions for Use (IFU) for: Gelsoft Plus Bifurcate, Gelsoft Plus Ax-Fem, GelsoftPlus ERS Ax-Fem, Gelweave Straight, Gelweave Trifurcate, Gelweave Ant-Flo, and Gelweave Val

Other PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER devices

All PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.